Bristol Myers Raises Earnings Guidance
- Published:
- First detected:
Insights by Echo AI
Bristol Myers Squibb raised its earnings guidance for the year after reporting higher profit and revenue in the latest quarter, driven by its portfolio of newer treatments. The drugmaker's outlook for 2026 was boosted by strong demand for most of its portfolio, led by newer medicines for heart conditions and cancer.
Source coverage
Aggregated
5
records merged
X / Twitter
5
4 unique
Telegram
0
0 unique
RSS
0
0 unique
5 Sources
Unlock Echo Intelligence
Move beyond the public feed. Monitor breaking stories across Telegram, X, and the web — with earlier visibility, clearer context, and complete control over your sources.
- Monitor Telegram, X, and web in one place
- Add any source, from niche channels to global outlets
- Build custom feeds around events, regions, entities, or keywords
- Merge duplicate coverage into one clear, source-transparent story
- Auto-translate summaries and full articles
- Search past coverage and use AI-powered editorial tools
